RIM
RS Investment Management Portfolio holdings
AUM
$9.73B
1-Year Return
3.46%
This Quarter Return
+5.44%
1 Year Return
+3.46%
3 Year Return
+50.76%
5 Year Return
–
10 Year Return
–
AUM
$9.73B
AUM Growth
-$385M
(-3.8%)
Cap. Flow
-$740M
Cap. Flow
% of AUM
-7.61%
Top 10 Holdings %
Top 10 Hldgs %
14.92%
Holding
438
New
62
Increased
134
Reduced
162
Closed
56
Top Buys
| 1 |
Integra LifeSciences
IART
|
$56.6M |
| 2 |
Kirby Corp
KEX
|
$52.4M |
| 3 |
LSXMK
Liberty Media Corporation Series C Liberty SiriusXM Common Stock
LSXMK
|
$44.7M |
| 4 |
Ingevity
NGVT
|
$43.4M |
| 5 |
WBMD
WebMD Health Corp.
WBMD
|
$40.3M |
Top Sells
| 1 |
Myriad Genetics
MYGN
|
$81.6M |
| 2 |
Red Robin
RRGB
|
$56.8M |
| 3 |
Steris
STE
|
$56.7M |
| 4 |
Dollar General
DG
|
$52.6M |
| 5 |
Zebra Technologies
ZBRA
|
$48.1M |
Sector Composition
| 1 | Technology | 17.29% |
| 2 | Healthcare | 14.02% |
| 3 | Financials | 14.01% |
| 4 | Consumer Discretionary | 13.08% |
| 5 | Industrials | 12.08% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
326
Simon Property Group
SPG
$59.5B
| $988K | 0.01% |
4,554
+1,149
| +34% | +$249K |
|
327
Ultragenyx Pharmaceutical
RARE
$3.07B
| $978K | 0.01% |
20,000
-390,548
| -95% | -$19.1M |
|
328
Ooma
OOMA
$346M
| $929K | 0.01% |
113,410
-99,600
| -47% | -$816K |
|
329
3M
MMM
$82.7B
| $834K | 0.01% |
5,699
| – | – |
|
330
UBS Group
UBS
$128B
| $834K | 0.01% |
66,354
| – | – |
|
331
Cisco
CSCO
$264B
| $813K | 0.01% |
28,333
+4,458
| +19% | +$128K |
|
332
Comscore
SCOR
$32.1M
| $807K | 0.01% |
1,691
-44,283
| -96% | -$21.1M |
|
333
Texas Instruments
TXN
$171B
| $759K | 0.01% |
12,108
+1,430
| +13% | +$89.6K |
|
334
Verizon
VZ
$187B
| $718K | 0.01% |
12,861
-308
| -2% | -$17.2K |
|
335
TJX Companies
TJX
$155B
| $715K | 0.01% |
18,522
| – | – |
|
|
TWTR
336
DELISTED
Twitter, Inc.
TWTR
| $656K | 0.01% |
38,780
-15,270
| -28% | -$258K |
|
337
Eaton
ETN
$136B
| $601K | 0.01% |
10,058
| – | – |
|
338
Amgen
AMGN
$153B
| $572K | 0.01% |
3,758
| – | – |
|
339
Keurig Dr Pepper
KDP
$38.9B
| $524K | 0.01% |
5,420
-3,937
| -42% | -$381K |
|
|
ADAP
340
Adaptimmune Therapeutics
ADAP
$10.9M
| $513K | 0.01% |
62,980
| – | – |
|
341
Honeywell
HON
$136B
| $504K | 0.01% |
+4,543
| New | +$504K |
|
342
Neurocrine Biosciences
NBIX
$14.3B
| $504K | 0.01% |
11,090
| – | – |
|
343
Scotiabank
BNS
$78.8B
| $486K | 0.01% |
7,679
+743
| +11% | +$47K |
|
344
McDonald's
MCD
$224B
| $484K | 0.01% |
4,024
-3,832
| -49% | -$461K |
|
345
Eli Lilly
LLY
$652B
| $479K | ﹤0.01% |
6,084
| – | – |
|
346
Mastercard
MA
$528B
| $400K | ﹤0.01% |
4,540
+1,309
| +41% | +$115K |
|
347
Ross Stores
ROST
$49.4B
| $391K | ﹤0.01% |
6,893
+724
| +12% | +$41.1K |
|
348
Canadian Natural Resources
CNQ
$63.2B
| $389K | ﹤0.01% |
20,234
+461
| +2% | +$8.86K |
|
349
Quaker Houghton
KWR
$2.51B
| $351K | ﹤0.01% |
3,938
-738
| -16% | -$65.8K |
|
350
MGE Energy Inc
MGEE
$3.1B
| $350K | ﹤0.01% |
+6,195
| New | +$350K |
|